A Clinical study in patients with dyslipidemia to determine the status of recognition and the percentage of patients achieving the target values for the management of each lipid parameter specified in the Japan Atherosclerosis Society Guidelines for the Prevention of Atherosclerotic Cardiovascular Diseases (2022 edition), and to follow-up the achievement of the target values by subsequent treatment approaches. - A Clinical study in patients with dyslipidemia to determine the status of recognition and the percentage of patients achieving the target values for the management of each lipid parameter specified in the Japan Atherosclerosis Society Guidelines for the Prevention of Atherosclerotic Cardiovascular Diseases (2022 edition), and to follow-up the achievement of the target values by subsequent treatment approaches.

Medical Corporation Chiseikai Tokyo Center Clinic0 个研究点目标入组 350 人开始时间: 2022年2月1日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1)Triglyceride level over 400 mg/dl at Visit 1(pre-SCR) 2)A history of malignant tumor within 5 years before screening 3)Persons deemed ineligible by the study physician

发起方

Medical Corporation Chiseikai Tokyo Center Clinic